期刊文献+

氢化可的松琥珀酸钠给药方式差异对重症脓毒血症继发休克患者生命体征、动态血糖指标及死亡率的影响 被引量:12

Influence of different administration methods of Hydrocortisone Sodium Succinate on vital signs, dynamic glycemic indexes and mortality of severe sepsis patients with secondary shock
下载PDF
导出
摘要 目的探讨氢化可的松琥珀酸钠静脉滴注与微量泵注给药对重症脓毒血症继发休克患者生命体征、动态血糖指标及死亡率的影响。方法选取该院2014年6月-2016年6月收治重症脓毒血症继发休克患者共100例。采用随机数字表法分为A组(50例)和B组(50例),在常规对症干预基础上分别给予氢化可的松琥珀酸钠静脉滴注与微量泵注给药。比较两组患者休克持续时间、ICU住院时间、总住院时间、28 d死亡率、治疗前后生命体征指标、治疗后血乳酸清除率和动态血糖监测指标水平。结果两组患者休克持续时间,ICU住院时间及总住院时间比较差异无统计学意义(P>0.05);两组患者28 d内死亡率比较差异无统计学意义(P>0.05);两组患者治疗前后HR、MAP及CVP水平组间比较差异无统计学意义(P>0.05);两组患者治疗后6、24及48 h血乳酸清除率比较差异无统计学意义(P>0.05);两组患者平均血糖值(MBG)水平比较差异无统计学意义(P>0.05);但B组患者最大血糖波动幅度(LAGE)、血糖波动系数(GV)及高血糖时间窗水平均低于A组(P<0.05)。结论氢化可的松琥珀酸钠2种给药方式治疗重症脓毒血症继发休克临床疗效相当,但微量泵注给药方式应用可有效提高血糖稳定性,维持机体代谢平衡。 Objective To investigate the influence of different administration methods including intravenous infusion and micro pump of Hydrocortisone Sodium Succinate (HSS) on vital signs, dynamic glycemic indexes and mortality of severe sepsis patients with secondary shock. Methods One hundred patients of severe sepsis with secondary shock treated from June 2014 to June 2016 were chosen and randomly divided into group A (50 patients) with intravenous infusion of HSS and group B (50 patients) with HSS administration by micro pump. Duration of shock, ICU stay time and total hospitalization time, 28 -d mortality, vital signs before and after treatment, blood lactate clearance rate and dynamic blood glucose monitoring indexes after treatment were compared between both groups. Results There was no significant difference in the duration of shock, the ICU stay time, the hospitalization time or the 28-d mortality between the two groups (P 〉 0.05). There was no significant difference in HR, MAP or CVP before and after treatment between the two groups (P 〉 0.05). There was no significant difference in the blood lactate clearance rate in 6, 24 and 48 h after treatment between the two groups (P 〉 0.05). There was no significant difference in the level of MBG between the two groups ( 〉 0.05). But the levels of LAGE, GV and high blood glucose time window of the group B were significant lower than those of the group A( 〈 0.05). ConclusionsIntravenous infusion and micro pump administration of Hydrocortisone Sodium Succinate possess the same clinical effect in the treatment of severe sepsis with secondary shock. However, micro pump administration can efficiently improve the stability of blood glucose and maintain the metabolic balance of the body.
出处 《中国现代医学杂志》 CAS 北大核心 2017年第13期82-85,共4页 China Journal of Modern Medicine
关键词 糖皮质激素 脓毒血症 休克 给药方式 glucocorticoid sepsis shock administration
  • 相关文献

参考文献4

二级参考文献46

  • 1王洪霞,刘健.血小板在脓毒症中的作用[J].医学综述,2005,11(5):455-456. 被引量:9
  • 2姚咏明,孟海东.脓毒症高血糖与胰岛素强化治疗策略[J].中国危重病急救医学,2006,18(2):68-70. 被引量:84
  • 3叶文,王锦权,陶晓根.脓毒症与凝血功能紊乱[J].医学综述,2006,12(5):296-298. 被引量:16
  • 4王洪霞,刘健,马树林,闫素英.血小板水平在危重病临床监测中的意义[J].中国危重病急救医学,2006,18(4):251-251. 被引量:13
  • 5韩传操.凝血功能检测及其临床意义的探讨[J].徐州医学院学报,2007,27(2):124-125. 被引量:7
  • 6管向东,刘大为,邱海波,等.重症医学专科资质培训教材[M].北京:人民卫生出版社,2009:43.
  • 7Marshall J C,Cook D J,Christou N V,et al.Multiple organdysfunction score:a reliable descriptor of a complex clinicaloutcome[J].Crit Care Med,1995,23(10):1638-1652.
  • 8Khwannimit B,Bhurayanontachai R.The epidemiology of,andrisk factors for,mortality from severe sepsis and septic shock ina tertiary-care university hospital setting[J].Epidemiol Infect,2009,137(9):1333-1341.
  • 9Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock : 2008 [ J ]. Crit Care Med, 2008,36 ( 1 ) : 296-327.
  • 10Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [ J ]. Crit Care Med, 2004,32 (3) : 858-873.

共引文献172

同被引文献133

引证文献12

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部